Chinese General Practice ›› 2023, Vol. 26 ›› Issue (24): 2997-3004.DOI: 10.12114/j.issn.1007-9572.2023.0029
Special Issue: 男性健康最新文章合辑; 运动相关研究最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2022-12-19
Revised:
2023-03-16
Published:
2023-08-20
Online:
2023-04-03
Contact:
SUN Lixia
通讯作者:
孙丽霞
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0029
变量 | 总人群(N=924) | Q1组(n=220) | Q2组(n=240) | Q3组(n=230) | Q4组(n=234) | 检验统计量值 | P值 |
---|---|---|---|---|---|---|---|
一般情况 | |||||||
年龄( | 36.9±7.7 | 34.9±7.8 | 35.4±7.4 | 37.2±7.2a | 40.1±7.3abc | 23.26d | <0.01 |
高脂血症〔例(%)〕 | 361(39.07) | 49(22.27) | 85(35.42) | 105(45.65) | 122(52.14)abc | 48.39 | <0.01 |
高血压〔例(%)〕 | 318(34.42) | 59(26.82) | 62(25.83) | 80(34.78) | 117(50.00)abc | 38.65 | <0.01 |
降压药史〔例(%)〕 | 92(9.96) | 11(5.00) | 16(6.67) | 23(10.00) | 42(17.95)abc | 25.60 | <0.01 |
饮酒史〔例(%)〕 | 519(56.17) | 117(53.18) | 126(52.50) | 135(58.70) | 141(60.26) | 4.29 | 0.23 |
吸烟史〔例(%)〕 | 566(61.26) | 143(65.00) | 146(60.83) | 143(62.17) | 134(57.26) | 2.97 | 0.40 |
体育锻炼〔例(%)〕 | 344(37.23) | 84(38.18) | 87(36.25) | 97(42.17) | 76(32.48) | 4.85 | 0.18 |
人体测量学指标 | |||||||
体质量( | 76.26±12.32 | 75.51±11.94 | 76.05±12.47 | 76.10±13.08 | 77.33±11.76 | 0.90d | 0.44 |
BMI( | 26.29±3.85 | 25.93±3.80 | 26.08±3.83 | 26.31±4.21 | 26.83±3.50 | 2.42d | 0.06 |
腰围( | 89.66±9.68 | 89.18±9.46 | 88.91±9.68 | 89.36±10.43 | 91.16±9.02 | 2.61d | 0.05 |
SBP( | 134±14 | 133±12 | 132±15 | 135±14 | 137±14ab | 6.42d | <0.01 |
DBP( | 85±12 | 84±12 | 84±12 | 85±13 | 88±10ab | 7.45d | <0.01 |
生化检测指标 | |||||||
空腹血糖〔M(P25,P75),mmol/L〕 | 5.40(5.00,5.82) | 4.74(4.50,4.88) | 5.20(5.10,5.30)a | 5.57(5.50,5.69)ab | 6.22(5.99,6.59)abc | 374.54e | <0.01 |
hs-CRP〔M(P25,P75),mg/L〕 | 0.24(0.01,1.40) | 1.19(0.30,2.60) | 0.25(0.01,1.70)a | 0.16(0.01,1.10)a | 0.11(0.01,0.36)ab | 115.97e | <0.01 |
三酰甘油〔M(P25,P75),mmol/L〕 | 1.23(0.83,1.95) | 1.00(0.75,1.59) | 1.19(0.80,1.84) | 1.32(0.84,2.12)a | 1.34(1.00,2.13)a | 23.33e | <0.01 |
总胆固醇( | 4.79±1.10 | 4.55±0.96 | 4.64±1.00 | 4.99±1.32ab | 4.96±1.03ab | 9.52d | <0.01 |
HDL-C( | 1.40±0.35 | 1.45±0.40 | 1.42±0.37 | 1.38±0.33 | 1.35±0.30a | 4.58d | <0.01 |
LDL-C( | 2.81±0.82 | 2.68±0.76 | 2.76±0.71 | 2.81±0.71 | 2.98±1.05ab | 5.22d | <0.01 |
Table 1 Comparison of epidemiological survey data of the subjects
变量 | 总人群(N=924) | Q1组(n=220) | Q2组(n=240) | Q3组(n=230) | Q4组(n=234) | 检验统计量值 | P值 |
---|---|---|---|---|---|---|---|
一般情况 | |||||||
年龄( | 36.9±7.7 | 34.9±7.8 | 35.4±7.4 | 37.2±7.2a | 40.1±7.3abc | 23.26d | <0.01 |
高脂血症〔例(%)〕 | 361(39.07) | 49(22.27) | 85(35.42) | 105(45.65) | 122(52.14)abc | 48.39 | <0.01 |
高血压〔例(%)〕 | 318(34.42) | 59(26.82) | 62(25.83) | 80(34.78) | 117(50.00)abc | 38.65 | <0.01 |
降压药史〔例(%)〕 | 92(9.96) | 11(5.00) | 16(6.67) | 23(10.00) | 42(17.95)abc | 25.60 | <0.01 |
饮酒史〔例(%)〕 | 519(56.17) | 117(53.18) | 126(52.50) | 135(58.70) | 141(60.26) | 4.29 | 0.23 |
吸烟史〔例(%)〕 | 566(61.26) | 143(65.00) | 146(60.83) | 143(62.17) | 134(57.26) | 2.97 | 0.40 |
体育锻炼〔例(%)〕 | 344(37.23) | 84(38.18) | 87(36.25) | 97(42.17) | 76(32.48) | 4.85 | 0.18 |
人体测量学指标 | |||||||
体质量( | 76.26±12.32 | 75.51±11.94 | 76.05±12.47 | 76.10±13.08 | 77.33±11.76 | 0.90d | 0.44 |
BMI( | 26.29±3.85 | 25.93±3.80 | 26.08±3.83 | 26.31±4.21 | 26.83±3.50 | 2.42d | 0.06 |
腰围( | 89.66±9.68 | 89.18±9.46 | 88.91±9.68 | 89.36±10.43 | 91.16±9.02 | 2.61d | 0.05 |
SBP( | 134±14 | 133±12 | 132±15 | 135±14 | 137±14ab | 6.42d | <0.01 |
DBP( | 85±12 | 84±12 | 84±12 | 85±13 | 88±10ab | 7.45d | <0.01 |
生化检测指标 | |||||||
空腹血糖〔M(P25,P75),mmol/L〕 | 5.40(5.00,5.82) | 4.74(4.50,4.88) | 5.20(5.10,5.30)a | 5.57(5.50,5.69)ab | 6.22(5.99,6.59)abc | 374.54e | <0.01 |
hs-CRP〔M(P25,P75),mg/L〕 | 0.24(0.01,1.40) | 1.19(0.30,2.60) | 0.25(0.01,1.70)a | 0.16(0.01,1.10)a | 0.11(0.01,0.36)ab | 115.97e | <0.01 |
三酰甘油〔M(P25,P75),mmol/L〕 | 1.23(0.83,1.95) | 1.00(0.75,1.59) | 1.19(0.80,1.84) | 1.32(0.84,2.12)a | 1.34(1.00,2.13)a | 23.33e | <0.01 |
总胆固醇( | 4.79±1.10 | 4.55±0.96 | 4.64±1.00 | 4.99±1.32ab | 4.96±1.03ab | 9.52d | <0.01 |
HDL-C( | 1.40±0.35 | 1.45±0.40 | 1.42±0.37 | 1.38±0.33 | 1.35±0.30a | 4.58d | <0.01 |
LDL-C( | 2.81±0.82 | 2.68±0.76 | 2.76±0.71 | 2.81±0.71 | 2.98±1.05ab | 5.22d | <0.01 |
变量 | 总人群(N=924) | Q1组(n=220) | Q2组(n=240) | Q3组(n=230) | Q4组(n=234) | F(H)值 | P值 |
---|---|---|---|---|---|---|---|
SBP1( | 132±15 | 130±14 | 131±15 | 132±16 | 135±16ab | 4.15 | <0.01 |
SBP2( | 132±15 | 130±14 | 132±15 | 132±15 | 135±15ab | 6.01 | <0.01 |
∆SBP〔M(P25,P75),mmHg〕 | 1(-5,6) | 0(-7,6) | 1(-4,6) | 0(-5,6) | 1(-5,7) | 4.54e | 0.21 |
DBP1( | 79±11 | 77±11 | 78±11 | 79±11 | 82±10ab | 8.04 | <0.01 |
DBP2( | 79±11 | 78±11 | 78±11 | 79±11 | 82±10abc | 9.62 | <0.01 |
∆DBP〔M(P25,P75),mmHg〕 | 0(-3,4) | 0(-3,4) | 0(-4,5) | 0(-3,4) | 1(-3,5) | 1.86e | 0.60 |
MAP1( | 99.17±12.50 | 97.23±12.19 | 98.03±12.24 | 99.28±13.03 | 102.04±12.08ab | 6.66 | <0.01 |
MAP2( | 99.44±11.98 | 97.57±11.14 | 98.74±12.14 | 99.39±12.10 | 101.97±12.10ab | 5.63 | <0.01 |
∆MAP〔M(P25,P75),mmHg〕 | 0.30(-4.20,5.10) | 0.80(-3.70,5.40) | 0.30(-3.80,5.50) | -0.05(-4.70,4.30) | -0.15(-4.50,4.90) | 1.70e | 0.64 |
HR1( | 80±13 | 80±12 | 79±12 | 81±12 | 81±12 | 2.14 | 0.09 |
HR2( | 86±14d | 85±13d | 85±14d | 85±12d | 87±14 | 1.34 | 0.26 |
∆HR〔M(P25,P75),次/min〕 | 5(0,10) | 6(0,11) | 5(0,11) | 4(-1,8) | 5(0,11) | 5.29e | 0.15 |
baPWV1( | 1 375.98±209.61 | 1 351.63±198.92 | 1 345.50±204.86 | 1 384.63±216.83 | 1 421.65±209.58abc | 6.63 | <0.01 |
baPWV2( | 1 342.24±208.82d | 1 309.95±194.19d | 1 312.10±208.65d | 1 343.84±203.35d | 1 401.92±215.65abcd | 10.08 | <0.01 |
∆baPWV〔M(P25,P75),cm/s〕 | -36.0 (-87.0,24.0) | -45.5 (-93.0,12.5) | -36.5 (-85.0,19.5) | -39.5 (-95.0,18.0) | -23.0 (-77.0,35.0) | 7.51e | 0.06 |
MET( | 12.16±2.55 | 12.42±2.78 | 12.21±2.26 | 12.22±2.78 | 11.79±2.33 | 2.49 | 0.06 |
VO2max( | 42.56±8.91 | 43.50±9.71 | 42.73±7.89 | 42.78±9.74 | 41.29±8.14 | 2.49 | 0.06 |
峰值HR( | 139.35±14.65 | 139.40±14.90 | 139.25±15.62 | 140.14±13.69 | 138.61±14.33 | 0.43 | 0.73 |
Time( | 7.13(4.94,11.16) | 7.51(5.41,11.37) | 7.38(4.92,12.61) | 7.03(5.00,11.15) | 6.67(4.73,9.55) | 8.22e | 0.06 |
Table 2 Comparison of baPWV-related data before and after the secondary load test of the power vehicle bicycle
变量 | 总人群(N=924) | Q1组(n=220) | Q2组(n=240) | Q3组(n=230) | Q4组(n=234) | F(H)值 | P值 |
---|---|---|---|---|---|---|---|
SBP1( | 132±15 | 130±14 | 131±15 | 132±16 | 135±16ab | 4.15 | <0.01 |
SBP2( | 132±15 | 130±14 | 132±15 | 132±15 | 135±15ab | 6.01 | <0.01 |
∆SBP〔M(P25,P75),mmHg〕 | 1(-5,6) | 0(-7,6) | 1(-4,6) | 0(-5,6) | 1(-5,7) | 4.54e | 0.21 |
DBP1( | 79±11 | 77±11 | 78±11 | 79±11 | 82±10ab | 8.04 | <0.01 |
DBP2( | 79±11 | 78±11 | 78±11 | 79±11 | 82±10abc | 9.62 | <0.01 |
∆DBP〔M(P25,P75),mmHg〕 | 0(-3,4) | 0(-3,4) | 0(-4,5) | 0(-3,4) | 1(-3,5) | 1.86e | 0.60 |
MAP1( | 99.17±12.50 | 97.23±12.19 | 98.03±12.24 | 99.28±13.03 | 102.04±12.08ab | 6.66 | <0.01 |
MAP2( | 99.44±11.98 | 97.57±11.14 | 98.74±12.14 | 99.39±12.10 | 101.97±12.10ab | 5.63 | <0.01 |
∆MAP〔M(P25,P75),mmHg〕 | 0.30(-4.20,5.10) | 0.80(-3.70,5.40) | 0.30(-3.80,5.50) | -0.05(-4.70,4.30) | -0.15(-4.50,4.90) | 1.70e | 0.64 |
HR1( | 80±13 | 80±12 | 79±12 | 81±12 | 81±12 | 2.14 | 0.09 |
HR2( | 86±14d | 85±13d | 85±14d | 85±12d | 87±14 | 1.34 | 0.26 |
∆HR〔M(P25,P75),次/min〕 | 5(0,10) | 6(0,11) | 5(0,11) | 4(-1,8) | 5(0,11) | 5.29e | 0.15 |
baPWV1( | 1 375.98±209.61 | 1 351.63±198.92 | 1 345.50±204.86 | 1 384.63±216.83 | 1 421.65±209.58abc | 6.63 | <0.01 |
baPWV2( | 1 342.24±208.82d | 1 309.95±194.19d | 1 312.10±208.65d | 1 343.84±203.35d | 1 401.92±215.65abcd | 10.08 | <0.01 |
∆baPWV〔M(P25,P75),cm/s〕 | -36.0 (-87.0,24.0) | -45.5 (-93.0,12.5) | -36.5 (-85.0,19.5) | -39.5 (-95.0,18.0) | -23.0 (-77.0,35.0) | 7.51e | 0.06 |
MET( | 12.16±2.55 | 12.42±2.78 | 12.21±2.26 | 12.22±2.78 | 11.79±2.33 | 2.49 | 0.06 |
VO2max( | 42.56±8.91 | 43.50±9.71 | 42.73±7.89 | 42.78±9.74 | 41.29±8.14 | 2.49 | 0.06 |
峰值HR( | 139.35±14.65 | 139.40±14.90 | 139.25±15.62 | 140.14±13.69 | 138.61±14.33 | 0.43 | 0.73 |
Time( | 7.13(4.94,11.16) | 7.51(5.41,11.37) | 7.38(4.92,12.61) | 7.03(5.00,11.15) | 6.67(4.73,9.55) | 8.22e | 0.06 |
模型 | 自变量 | B(95%CI) | SE | t值 | P值 |
---|---|---|---|---|---|
模型1 | Q4 | ||||
Q1 | -30.10(-47.39,-12.82) | 8.81 | 6.66 | <0.01 | |
Q2 | -22.54(-39.48,-5.60) | 8.63 | -2.61 | 0.01 | |
Q3 | -25.38(-42.39,-8.37) | 8.67 | -2.93 | <0.01 | |
模型2 | Q4 | ||||
Q1 | -18.82(-36.69,-0.94) | 9.11 | -2.07 | 0.04 | |
Q2 | -12.71(-29.74,4.32) | 8.68 | -1.47 | 0.14 | |
Q3 | -19.58(-36.45,-2.71) | 8.60 | -2.28 | 0.02 | |
模型3 | Q4 | ||||
Q1 | -18.96(-36.96,-0.96) | 9.17 | -2.07 | 0.04 | |
Q2 | -12.37(-29.35,4.60) | 8.65 | -1.43 | 0.15 | |
Q3 | -15.23(-31.95,1.49) | 8.52 | -1.79 | 0.07 |
Table 3 Generalized linear model analysis of the effect of fasting blood glucose level on baPWV before and after the secondary load test of the power vehicle bicycle
模型 | 自变量 | B(95%CI) | SE | t值 | P值 |
---|---|---|---|---|---|
模型1 | Q4 | ||||
Q1 | -30.10(-47.39,-12.82) | 8.81 | 6.66 | <0.01 | |
Q2 | -22.54(-39.48,-5.60) | 8.63 | -2.61 | 0.01 | |
Q3 | -25.38(-42.39,-8.37) | 8.67 | -2.93 | <0.01 | |
模型2 | Q4 | ||||
Q1 | -18.82(-36.69,-0.94) | 9.11 | -2.07 | 0.04 | |
Q2 | -12.71(-29.74,4.32) | 8.68 | -1.47 | 0.14 | |
Q3 | -19.58(-36.45,-2.71) | 8.60 | -2.28 | 0.02 | |
模型3 | Q4 | ||||
Q1 | -18.96(-36.96,-0.96) | 9.17 | -2.07 | 0.04 | |
Q2 | -12.37(-29.35,4.60) | 8.65 | -1.43 | 0.15 | |
Q3 | -15.23(-31.95,1.49) | 8.52 | -1.79 | 0.07 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
韩旭,刘倩,马一涵,等. 非糖尿病人群空腹血糖水平对动脉僵硬度进展的影响[J]. 中华高血压杂志,2021,29(1):41-47. DOI:10.16439/j.issn.1673-7245.2021.01.010.
|
[19] |
|
[20] |
|
[21] |
|
[22] |
体育总局关于开展第五次国民体质监测的通知[EB/OL].(2019-02-02)[2022-08-02].
|
[23] |
|
[24] |
|
[25] |
中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志,2019,24(1):24-56.
|
[26] |
中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志,2007,35(5):390-419. DOI:10.3760/j.issn:0253-3758.2007.05.003.
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||